Table 1. Demographic and clinical characteristics of HHC with TST conversion.
Totaln = 122 | Stable Converters n = 97 (79.5%) | Revertersn = 25 (20.5%) | P-value | |
Gender | ||||
Male | 45 | 33 (34%) | 12 (48%) | 0.20 |
Female | 77 | 64 (66%) | 13 (52%) | |
Age (median) | 122 | 13.0 | 7.0 | 0.07 |
Age group | ||||
< 5 years | 24 | 15 (15%) | 9 (36%) | 0.37 |
5–15 years | 55 | 46 (47%) | 9 (36%) | |
16–25 years | 32 | 26 (27%) | 6 (24%) | |
26–45 years | 8 | 7 (7%) | 1 (4%) | |
> 45 years | 3 | 3 (3%) | 0 | |
BCG scar present | ||||
Yes | 82 | 67 (69%) | 15 (60%) | 0.44 |
No | 25 | 18 (19%) | 7 (28%) | |
Uncertain | 15 | 12 (12%) | 3 (12%) | |
BMI (median) | 122 | 18.2 | 16.8 | 0.44 |
Treated for TB Disease | ||||
Yes | 0 | 0 | 0 | - |
No | 122 | 97 (100%) | 25 (100%) |